Yves Bikorimana: Before Wash vs After Wash in Blood Grouping
Yves Bikorimana, CEO at MedData-Rwanda and Lab Scientist at The University Teaching Hospital of Kigali-Chuk, shared a post on LinkedIn:
“Before Wash vs After Wash in Blood Grouping – Why It Matters
In immunohematology, small technical details can completely change interpretation. This image perfectly demonstrates the importance of the saline wash step during blood grouping and antibody testing.
Let’s break it down
Left Side: Tube Method (Cell Washing)
Before Wash
We see a red cell suspension with plasma and possible interfering substances still present. Proteins, rouleaux formation, or excess antibodies can create pseudo-agglutination or mask true reactions.
After 3× Saline Wash plus Centrifugation
The supernatant becomes clear, and only packed red cells remain at the bottom.
Why is this important?
- Removes unbound antibodies
- Eliminates excess plasma proteins
- Prevents false reactions
- Improves accuracy of antiglobulin testing
Washing ensures we are detecting true antigen–antibody reactions, not artifacts.
Right Side: Slide/Card Agglutination (Anti-A, Anti-B, Anti-D)
Before Wash
Anti-D appears weakly positive — but note the label: False agglutination.
Sometimes:
- Rouleaux formation
- Fibrin strands
- High protein states
- Improper cell suspension
can mimic agglutination.
After Wash
The false Anti-D reaction disappears.
Result interpretation becomes clear and reliable.
- Anti-A: Negative
- Anti-B: Negative
- Anti-D: Negative
Final Blood Group: O Rh(D) Negative
Key Takeaway
In transfusion medicine, accuracy is patient safety.
A simple saline wash step can:
- Prevent mislabeling of blood groups
- Avoid incompatible transfusions
- Reduce risk of hemolytic transfusion reactions
In laboratory science, precision isn’t optional — it’s ethical responsibility.”

Stay updated with Hemostasis Today.
-
Aug 31, 2026, 17:11Chokri Ben Lamine: Early Recognition and Immediate Treatment of Catastrophic APS
-
Aug 31, 2026, 17:06Nikolaos Ktenopoulos: COMPASS-ARTeCAT Trial Highlights Arterial Thrombosis in Patients With Cancer
-
Aug 31, 2026, 17:01Mark Kaplan: Same LDL-C, Different Coagulation, Different Outcomes, in FH
-
Aug 31, 2026, 16:55Kemal Karaagac: Milvexian Did Not Reduce Ischemic Events but Did Not Increase Fatal Bleeding
-
Aug 31, 2026, 16:47Improving Outcomes in AF-Related Stroke Beyond Anticoagulation at ESC 2026 – ESO
-
Aug 31, 2026, 16:39Shariq Shamim: Are We Going to Start DOAC post TAVI not DAPT?
-
Aug 31, 2026, 16:30Bartosz Hudzik: 5th Universal MI Definition Moves Closer to Biology in Women
-
Aug 31, 2026, 16:13Seema Dawood: Nucleated Red Blood Cells – What They Tell Us on a Peripheral Smear
-
Aug 31, 2026, 16:02Antonio Sorropago: Major Updates in Structural Heart Interventions